When the Department of Financial Services made its annual announcement about health insurance price increases last week, it neglected to mention one thing: how much the prices were increasing.

The department’s press release spelled out in detail how much it had rolled back the hikes requested by health plans – and how much consumers would supposedly save as a result – but never gave the bottom-line impact on rates for 2024.

For that basic information, it was necessary to follow a link to a separate chart.

Here is what the department chose not to say: 

Next year’s state-regulated premiums are going up by an average of 12 percent for individual plans and 7 percent for small groups. Those increases are roughly four times and two times the current rate of inflation, respectively.

They translate to about $720 million in additional costs for 1.1 million affected consumers and their employers, or about $650 per person, in a state that already pays some of the highest premiums in the country.

Leaving that unpleasant news out of a press release doesn’t make it any less true.

Both the underlying facts and the department’s evasiveness point to a deeper problem: The state’s regulatory system for health premiums, known as “prior approval,” is failing as a strategy to control costs.

Although the rate hikes approved by DFS are generally much smaller than what the plans request, they can still be substantial. This year’s approved increases for individual plans ranged from a weighted average of 3 percent for small group customers of UnitedHealthcare to 25 percent for individual policyholders at Emblem (also known as HIP) and Independent Health Benefits Corp.

When weighted by the membership of each plan, the average premium increase for individual plans in 2024 will be 12.4 percent, or about four times the rate of inflation, and the average increase for small groups will be 7.4 percent, or about double the rate of inflation.

This round of hikes is not particularly unusual. Over the past 10 years, the average annual increase has been almost 9 percent for individual plans and 7 percent for small groups.

The prior approval regime applies primarily to individual policies and small groups plans (defined as 100 employees or less) which together cover 1.1 million New Yorkers or about one-tenth of the commercially insured market. Most large employers are self-insured and exempt from state regulation under federal law, meaning prior approval has no direct effect on the bulk of health coverage costs.

Still, prior approval does not appear to be effectively controlling costs even for the portion of the market it regulates.

As reported last month on this blog, New York’s average cost for employer-sponsored coverage for a single employee in 2022 was the highest of any state and 18 percent above the national average.

According to the same federal survey, New York’s price disparity has been consistently wider for the small groups subject to prior approval than it is for large groups which are exempt.

Over the past three years, premiums for groups of 50 or fewer in New York averaged 22 percent higher than the nationwide norm, while the gap for groups of 1,000 or more was 12 percent (see chart).

 

This makes clear – contrary to the DFS's spin – that the prior approval process is not "saving" money for consumers in the long run, but allowing costs to continue their upward spiral.

If state officials truly want affordable health care, they should focus less on the symptom of premiums than on the underlying drivers of medical costs – which in New York include heavy taxation, inefficient regulation, a lack of transparency in hospital pricing and increased consolidation among medical providers.

 

About the Author

Bill Hammond

As the Empire Center’s senior fellow for health policy, Bill Hammond tracks fast-moving developments in New York’s massive health care industry, with a focus on how decisions made in Albany and Washington affect the well-being of patients, providers, taxpayers and the state’s economy.

Read more by Bill Hammond

You may also like

How Medicaid ‘Expansion’ Changes Could Affect New York

As House Republicans consider cutbacks to federal Medicaid funding, their focus has turned to the so-called expansion population. Although the details of remain undetermined, the s Read More

New York’s Home Health Workforce Jumps by Another 10 Percent

New York's home health employment is continuing to soar, growing by 57,000 jobs or 10 percent from 2023 to 2024, according to newly released data from the U.S. Bureau of Labor Statistics. Read More

Immigrant Enrollment in ‘Emergency Medicaid’ Surges to 480,000

One of the biggest drivers of New York's Medicaid enrollment growth over the past decade has been "emergency Medicaid" for undocumented immigrants, newly released state records show. Read More

Upstate Insurance Customers Pay the Price for Medicare’s Hospital Rate Hike

A billion-dollar Medicare windfall for upstate hospitals has turned into a crisis for upstate health insurers that's threatening to disrupt coverage for millions of New Yorkers. The Read More

New York’s Proposed ‘MCO Tax’ Would Generate a Fraction of What Lawmakers Expected

The Hochul administration's proposed "MCO tax" would generate far less than the $4 billion in extra federal aid anticipated by state lawmakers when they approved the concept this spring, according to documents obtained by t Read More

Hochul Hides the Specifics of a Looming Tax on Health Insurance

The Hochul administration has requested federal approval for a multibillion-dollar "MCO tax" on health plans without announcing the move or providing details to the public. As by l Read More

New Yorkers’ Health Costs Spiral as Officials Take Credit for ‘Savings’

The latest round of health insurance premium hikes announced by New York regulators adds to evidence that state policies are drowning consumers instead of helping them. Late last mo Read More

What Paul Francis Got Wrong About the Empire Center’s Nursing Home Research

In February 2021, the Empire Center published the first independent analysis of the Cuomo's administration much-debated directive ordering Covid-positive patients into nursing homes. The report found that the directive was associated with a statistically significant increase in resident deaths in the homes that admitted the  infected patients. Read More